FindTrial
Sign In

High dose rate brachytherapy

RADIATION7 trials

Sponsors

Canadian Cancer Trials Group, Aarhus University Hospital, British Columbia Cancer Agency, N.N. Petrov National Medical Research Center of Oncology, M.D. Anderson Cancer Center

Conditions

Biochemical Relapse Free SurvivalCervical CancerCholangiocarcinoma MetastaticComplications Rates (Erectile Dysfunction, GI, GU Complications)Liver Malignant TumorsMelanomaOligometastatic Prostate CancerPancreatic Cancer

Phase 2

Intra-lesional Tumor Boost for Bulky Cervical Cancer
RecruitingNCT07435376
Seoul National University Bundang HospitalCervical Cancer, Squamous Cell Carcinoma of Cervix
Start: 2025-02-23End: 2028-11-30Target: 17Updated: 2026-02-27

Unknown Phase

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
Active, not recruitingNCT02960087
Canadian Cancer Trials GroupProstate Carcinoma
Start: 2017-03-06End: 2029-10-30Updated: 2026-04-22
Salvage HDR for Locally Recurrent Prostate Cancer
RecruitingNCT04231006
Aarhus University HospitalProstate Cancer
Start: 2021-04-01End: 2035-03-01Target: 50Updated: 2021-07-21
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
RecruitingNCT04610372
British Columbia Cancer AgencyOligometastatic Prostate Cancer
Start: 2021-07-12End: 2033-06-30Target: 168Updated: 2026-05-06
HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer
NCT04870567
N.N. Petrov National Medical Research Center of OncologyBiochemical Relapse Free Survival, Complications Rates (Erectile Dysfunction, GI, GU Complications)
Start: 2018-04-01End: 2025-04-30Target: 350Updated: 2021-05-03
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
RecruitingNCT05053555
M.D. Anderson Cancer CenterCholangiocarcinoma Metastatic, Liver Malignant Tumors, Melanoma +1
Start: 2022-04-24End: 2027-01-31Target: 60Updated: 2026-05-22
Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
RecruitingNCT06508567
University Health Network, TorontoProstate Cancer, Prostate Cancer Recurrent
Start: 2024-08-08End: 2031-03-01Target: 20Updated: 2026-05-26